🏆 Alithea Bio Wins Freiburger Innovationspreis 2025 for HLA‑Compass

Alithea Bio has been honored with the Freiburger Innovationspreis 2025 for its groundbreaking HLA‑Compass platform — a unique SaaS solution that uses AI and ultra‑sensitive mass spectrometry to reveal critical HLA peptides on cancer and healthy tissue.

With over 17 million data points and 10,000+ potential drug targets, HLA‑Compass is helping make personalized immunotherapy safer, faster, and more precise.

Watch the video to learn how our work is transforming cancer research and paving the way for digital twins in oncology.